Advertisement

Internal and Emergency Medicine

, Volume 9, Issue 3, pp 303–309 | Cite as

Helicobacter pylori secreted peptidyl prolyl cis, trans-isomerase drives Th17 inflammation in gastric adenocarcinoma

  • Amedeo Amedei
  • Fabio Munari
  • Chiara Della Bella
  • Elena Niccolai
  • Marisa Benagiano
  • Lapo Bencini
  • Fabio Cianchi
  • Marco Farsi
  • Giacomo Emmi
  • Giuseppe Zanotti
  • Marina de Bernard
  • Manikuntala Kundu
  • Mario Milco D’EliosEmail author
IM - ORIGINAL

Abstract

Helicobacter pylori infection is characterized by an inflammatory infiltrate, consisting mainly of neutrophils and T cells. This study was undertaken to evaluate the type of gastric T cell response elicited by the secreted peptidyl prolyl cis, trans-isomerase of H. pylori (HP0175) in patients with distal gastric adenocarcinoma. The cytokine profile and the effector functions of gastric tumor-infiltrating lymphocytes (TILs) specific for HP0175 was investigated in 20 patients with distal gastric adenocarcinoma and H. pylori infection. The helper function of HP0175-specific TILs for monocyte MMP-2, MMP-9, and VEGF production was also investigated. TILs cells from H. pylori infected patients with distal gastric adenocarcinoma produced Interleukin (IL)-17 and IL-21 in response to HP0175. HP0175-specific TILs showed poor cytolytic activity while expressing helper activity for monocyte MMP-2, MMP-9 and VEGF production. These findings indicate that HP0175 is able to drive gastric Th17 response. Thus, HP0175, by promoting pro-inflammatory low cytotoxic TIL response, matrix degradation and pro-angiogenic pathways, may provide a link between H. pylori and gastric cancer.

Keywords

Gastric cancer Helicobacter pylori Pathogenesis Cytokines Th17 VEGF Matrix metalloproteinase 

Notes

Acknowledgments

This work was supported by Italian Ministry of University and Research Grant 2008C33HRL_003, the Italian Ministry of Health and the Istituto Superiore di Sanità (to M.M.D.E.), the Indian Council of Medical Research, Government of India (to M.K.) and Progetto di Eccellenza Fondazione Cassa di Risparmio di Padova e Rovigo and Associazione Italiana per la Ricerca sul Cancro Grant Regionale 2008 (to M.d.B.).

Conflict of interest

The authors have no financial conflict of interest.

References

  1. 1.
    Warren JR, Marshall BJ (1984) Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulcer ulceration. Lancet 1:1311–1315PubMedGoogle Scholar
  2. 2.
    Parsonnet J, Friedman GD, Vandersteen DP, Chang Y, Vogelman JH et al (1991) Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 325:1127–1131PubMedCrossRefGoogle Scholar
  3. 3.
    Wotherspoon AC, Doglioni C, Diss TC, Pan L, Moschini A et al (1993) Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet 342:575–577PubMedCrossRefGoogle Scholar
  4. 4.
    D’Elios MM, Appelmelk BJ, Amedei A, Bergman MP, Del Prete G (2004) Gastric autoimmunity: the role of Helicobacter pylori and molecular mimicry. Trends Mol Med 10:316–323PubMedCrossRefGoogle Scholar
  5. 5.
    Fox JG, Wang TC (2007) Inflammation, atrophy, and gastric cancer. J Clin Invest 117:60–69PubMedCentralPubMedCrossRefGoogle Scholar
  6. 6.
    IARC Working Group on the Evaluation of Carcinogenic Risks to Humans (1994) Schistosomes, liver flukes and Helicobacter pylori. Lyon, 7–14 June 1994. IARC Monogr Eval Carcinog Risks Hum 61:1–241Google Scholar
  7. 7.
    D’Elios MM, Manghetti M, De Carli M, Costa F, Baldari CT et al (1997) Th1 effector cells specific for Helicobacter pylori in the gastric antrum of patients with peptic ulcer disease. J Immunol 158:962–967PubMedGoogle Scholar
  8. 8.
    Kaparakis M, Philpott DJ, Ferrero RL (2007) Mammalian NLR proteins; discriminating foe from friend. Immunol Cell Biol 85:495–502PubMedCrossRefGoogle Scholar
  9. 9.
    Amedei A, Cappon A, Codolo G, Cabrelle A, Polenghi A et al (2006) The neutrophil-activating protein of Helicobacter pylori promotes Th1 immune responses. J Clin Invest 116:1092–1101PubMedCentralPubMedCrossRefGoogle Scholar
  10. 10.
    Luzza F, Parrello T, Monteleone G, Sebkova L, Romano M et al (2000) Up-regulation of IL-17 is associated with bioactive IL-8 expression in Helicobacter pylori-infected human gastric mucosa. J Immunol 165:5332–5337PubMedGoogle Scholar
  11. 11.
    Shi Y, Liu XF, Zhuang Y, Zhang JY, Liu T et al (2010) Helicobacter pylori-induced Th17 response modulate Th1 cell responses, benefit bacterial growth, and contribute to pathology in mice. J Immunol 184:5121–5129PubMedCrossRefGoogle Scholar
  12. 12.
    Caruso R, Fina D, Peluso I, Fantini MC, Tosti C et al (2007) IL-21 is highly produced in Helicobacter pylori-infected gastric mucosa and promotes gelatinases synthesis. J Immunol 178:5957–5965PubMedGoogle Scholar
  13. 13.
    Volpe E, Servant N, Zollinger R, Bogiatzi SI, Hupe P et al (2008) Critical function for transforming growth factor-beta, interleukin 23 and proinflammatory cytokines in driving and modulating human TH-17 responses. Nat Immunol 9:650–657PubMedCrossRefGoogle Scholar
  14. 14.
    Korn T, Bettelli E, Oukkaì M, Kuchroo VK (2009) IL-17 and Th17 Cells. Annu Rev Immunol 27:485–517PubMedCrossRefGoogle Scholar
  15. 15.
    Pertovaara L, Kaipainen A, Mustonen T, Orpana A, Ferrara N et al (1994) Vascular endothelial growth factor is induced in response to transforming growth factor-beta in fibroblastic and epithelial cells. J Biol Chem 269:6271–6274PubMedGoogle Scholar
  16. 16.
    Ferrara N, Davis-Smyth T (1997) The biology of vascular endothelial growth factor. Endocr Rev 18:4–25PubMedCrossRefGoogle Scholar
  17. 17.
    Folkman J (2006) Angiogenesis. Annu Rev Med 57:1–18PubMedCrossRefGoogle Scholar
  18. 18.
    Miossec P, Korn T, Kuchroo VK (2009) Interleukin-17 and type 17 helper T cells. N Engl J Med 361:888–898PubMedCrossRefGoogle Scholar
  19. 19.
    Cone RE, Chattopadhyay S, Sharafieh R, Lemire Y, O’Rourke J et al (2009) T cell sensitivity to TGF-β is required for the effector function but not the generation of splenic CD8+ regulatory T cells induced via the injection of antigen into the anterior chamber. Int Immunol 21:567–574PubMedCentralPubMedCrossRefGoogle Scholar
  20. 20.
    Sebkova L, Pellicanò A, Monteleone G, Grazioli B, Guarnieri G et al (2004) Extracellular signal-regulated protein kinase mediates interleukin 17 (IL-17)-induced IL-8 secretion in Helicobacter pylori-infected human gastric epithelial cells. Infect Immun 72:5019–5026PubMedCentralPubMedCrossRefGoogle Scholar
  21. 21.
    Deryugina EI, Quigley JP (2006) Matrix metalloproteinases and tumor metastasis. Cancer Metastasis Rev 25:9–34PubMedCrossRefGoogle Scholar
  22. 22.
    Zhang B, Rong G, Wei H, Zhang M, Bi J et al (2008) The prevalence of Th17 cells in patients with gastric cancer. Biochem Biophys Res Commun 374:533–537PubMedCrossRefGoogle Scholar
  23. 23.
    Codolo G, Amedei A, Steere AC, Papinutto E, Cappon A et al (2008) Borrelia burgdorferi-NapA driven Th17 cell inflammation in Lyme arthritis. Arthritis Rheum 58:3609–3617PubMedCrossRefGoogle Scholar
  24. 24.
    Pathak SK, Basu S, Bhattacharyya A, Pathak S, Banerjee A et al (2006) TLR4-dependent NF-kappaB activation and mitogen- and stress-activated protein kinase 1-triggered phosphorylation events are central to Helicobacter pylori peptidyl prolyl cis-, trans-isomerase (HP0175)-mediated induction of IL-6 release from macrophages. J Immunol 177:7950–7958PubMedGoogle Scholar
  25. 25.
    Basu S, Pathak SK, Chatterjee G, Pathak S, Basu J et al (2008) Helicobacter pylori protein HP0175 transactivates epidermal growth factor receptor through TLR4 in gastric epithelial cells. J Biol Chem 283:32369–32376PubMedCrossRefGoogle Scholar
  26. 26.
    Basak C, Pathak SK, Bhattacharyya A, Pathak S, Basu J et al (2005) The secreted peptidyl prolyl cis, trans-isomerase HP0175 of Helicobacter pylori induces apoptosis of gastric epithelial cells in a TLR4- and apoptosis signal-regulating kinase 1-dependent manner. J Immunol 174:5672–5680PubMedGoogle Scholar
  27. 27.
    Amedei A, Niccolai E, Della Bella C, Cianchi F, Trallori G et al (2009) Characterization of tumor antigen peptide-specific T cells isolated from the neoplastic tissue of patients with gastric adenocarcinoma. Cancer Immunol Immunother 58:1819–1830PubMedCrossRefGoogle Scholar
  28. 28.
    D’Elios MM, Bergman MP, Azzurri A, Amedei A, Benagiano M et al (2001) H(+), K(+)-ATPase (proton pump) is the target autoantigen of Th1-type cytotoxic T cells in autoimmune gastritis. Gastroenterology 120:377–386PubMedCrossRefGoogle Scholar
  29. 29.
    D’Elios MM, Amedei A, Benagiano M, Azzurri A, Del Prete G (2005) Helicobacter pylori, T cells and cytokines: the “dangerous liaisons”. FEMS Immunol Med Microbiol 44:113–119PubMedCrossRefGoogle Scholar
  30. 30.
    Fox JG, Beck P, Dangler CA, Whary MT, Wang TC et al (2000) Concurrent enteric helminth infection modulates inflammation and gastric immune responses and reduces helicobacter-induced gastric atrophy. Nat Med 6:536–542PubMedCrossRefGoogle Scholar
  31. 31.
    D’Elios MM, Manghetti M, Almerigogna F, Amedei A, Costa F et al (1997) Different cytokine profile and antigen-specificity repertoire in Helicobacter pylori-specific T cell clones from the antrum of chronic gastritis patients with or without peptic ulcer. Eur J Immunol 27:1751–1755PubMedCrossRefGoogle Scholar
  32. 32.
    El-Omar EM, Carrington M, Chow WH, McColl KE, Bream JH et al (2000) Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 404:398–402PubMedCrossRefGoogle Scholar
  33. 33.
    El-Omar EM, Carrington M, Chow WH, McColl KE, Bream JH et al (2001) The role of interleukin-1 polymorphisms in the pathogenesis of gastric cancer. Nature 412:99–103PubMedCrossRefGoogle Scholar
  34. 34.
    Caruso R, Fina D, Paoluz OA, Del Vecchio Blanco G, Stolfi C et al (2008) IL-23-mediated regulation of IL-17 production in Helicobacter pylori-infected gastric mucosa. Eur J Immunol 38:470–478PubMedCrossRefGoogle Scholar
  35. 35.
    Zhang JY, Liu T, Guo H, Liu XF, Zhuang Y et al (2011) Induction of a Th17 cell response by Helicobacter pylori urease subunit B. J Immunol 216:803–810Google Scholar
  36. 36.
    D’Elios MM, Andersen LP (2009) Inflammation, immunity, and vaccines for H. pylori. Helicobacter 14(S1):21–28Google Scholar
  37. 37.
    Wu S, Rhee KJ, Albesiano E, Rabizadeh S, Wu X et al (2009) A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses. Nat Med 15:1016–1022PubMedCentralPubMedCrossRefGoogle Scholar
  38. 38.
    Langowski JL, Zhang X, Wu L, Mattson JD, Chen T et al (2006) IL-23 promotes tumour incidence and growth. Nature 442:461–465PubMedCrossRefGoogle Scholar
  39. 39.
    Meulmeester E, Ten Dijke P (2011) The dynamic roles of TGF-β in cancer. J Pathol 223:205–218PubMedCrossRefGoogle Scholar
  40. 40.
    Tuccillo C, Cuomo A, Rocco A, Martinelli E, Staibano S et al (2005) Vascular endothelial growth factor and neo-angiogenesis in H. pylori gastritis in humans. J Pathol 207:277–284PubMedCrossRefGoogle Scholar

Copyright information

© SIMI 2012

Authors and Affiliations

  • Amedeo Amedei
    • 1
    • 2
  • Fabio Munari
    • 3
  • Chiara Della Bella
    • 1
  • Elena Niccolai
    • 1
  • Marisa Benagiano
    • 1
  • Lapo Bencini
    • 4
  • Fabio Cianchi
    • 5
  • Marco Farsi
    • 4
  • Giacomo Emmi
    • 2
  • Giuseppe Zanotti
    • 3
  • Marina de Bernard
    • 3
  • Manikuntala Kundu
    • 6
  • Mario Milco D’Elios
    • 1
    • 2
    Email author
  1. 1.Department of Internal MedicineUniversity of FlorenceFlorenceItaly
  2. 2.Patologia MedicaAOU Careggi FirenzeFlorenceItaly
  3. 3.VIMM PaduaPaduaItaly
  4. 4.Division of General and Oncologic SurgeryAOU CareggiFlorenceItaly
  5. 5.Department of Medical and Surgical Critical CareUniversity of FlorenceFlorenceItaly
  6. 6.Department of ChemistryBose InstituteKolkataIndia

Personalised recommendations